Skip to Content

Kacital 1080 mg modified-release tablets

Licence status
Authorised: 02/08/2024
Active substances
Potassium citrate
Dosage Form
Modified-release tablet
Licence number
PA23382/002/001
Licence holder
XGX Pharma ApS

Licence information

ATC code
A12BA02 potassium citrate
Legal supply status
Product subject to prescription which may be renewed (B)
Place of sale
Supply through pharmacies only
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
02/08/2024